Learn More
Genscript Corporation Trastuzumab Immunogenicity Kit
Supplier: Genscript Corporation L01007
GenScript Trastuzumab Immunogenicity Kit (Bridging ELISA) is designed for detection of anti-Trastuzumab antibody in serum and plasma samples This kit utilizes a validated bridgingimmunoassay method based on the FDA EMA and NMPA Immunogenicity Guidelines Through rigorous validation studies the kit has been demonstrated high sensitivity specificity and is free from matrix effects It is an ideal tool for the analysis of ADA against Trastuzumab
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.